Please wait a minute...
2TMR Integrative Medicine  2019, 3: e19009.       DOI: 10.12032/TMRIM201903009
    
A review of the treatment of ankylosing spondylitis from liver and kidney
Teng Huang3, Ling-Jing Zhang1, Li-Na Zhang1, Zhi-Yong Zhao3, Bin Hao3,*()
1Hebei University, College of Traditional Chinese Medicine, Baoding, Hebei, China
2Hebei University, College of Life Sciences, Baoding, Hebei, China
3Chinese People's Liberation Army 252 Hosptital, Traditional Chinese Medicine Department, Baoding, Hebei, China
Download: HTML     PDF(430KB)
Export: BibTeX | EndNote (RIS)      

Highlights:

On the basis of tonifying liver and kidney, the clinical symptoms of Ankylosing spondylitis can be improved by promoting blood circulation, removing blood stasis and eliminating pathogenic factors.

Abstract

Ankylosing spondylitis is a kind of arthropathy of rheumatic immune disease. The pathogenesis of ankylosing spondylitis is not very clear in current medical research. Because of the recurrence of the disease and the prolongation of the disease, the quality of life of the patients has been seriously affected. Traditional Chinese medicine has long known its etiology and pathogenesis, and it is very effective in clinical treatment. Based on the theory of traditional Chinese medicine and modern physicians' understanding of its etiology and pathogenesis, and starting from the function and characteristics of liver and kidney, this paper explores the basis of treating ankylosing spondylitis from liver and kidney, with a view to providing new ideas for the clinical treatment of ankylosing spondylitis.



Key wordsAnkylosing spondylitis      Etiology and pathogenesis      Treatment of liver and kidney     
Published: 10 May 2019
Corresponding Authors: Hao Bin   
E-mail: 32219525@qq.com
Cite this article:

Teng Huang, Ling-Jing Zhang, Li-Na Zhang, Zhi-Yong Zhao, Bin Hao. A review of the treatment of ankylosing spondylitis from liver and kidney. 2TMR Integrative Medicine, 2019, 3: e19009.  

URL:

https://www.tmrjournals.com/im/EN/10.12032/TMRIM201903009     OR     https://www.tmrjournals.com/im/EN/Y2019/V3/IVolume 3/88888

1.   Hukuda S, Minami M, Saito T, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Anky-losing Spondylitis Society . J Rheumatol 2001, 28: 554-559.
2.   Silverstein FE, Graham DY.Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflam-matory drugs. Ann Intem Med 1995, 12: 241.
3.   Schoen RT, Vender RJ.Mcchenisms of nonsleroidal ant-inflammatory drug induced gastric. Am J Med 1989, 8: 449.
4.   Gan AH, Xu AG.Non-steroidal anti-inflammatory drugs and gastrointestinal diseases. R Med 2004, 14: 236.
5.   Tack J, Talley NJ, Camilleri M, et al. Functional gastrodenal disorders. Gastroenterology 2006, 1: 1466-1479.
6.   Deng XH, Huang F, Zhang JL, et al. Effect of thalidomide on remission of patients with ankylosing spondylitis after discontinuation of etanercept. Chin J Rheumatology 2009, 13: 765-768.
7.   Iqbal BN.Accumulation of methotrexate in human tissues following high-dose methotrexate therapy. Pak Med Assoc 1998, 48: 341.
8.   Gu YL, Zou HJ.One case of hepatic dysfunction caused by low dose methotrexate. Chin J Clin Pharm 2002, 11: 371.
9.   Zhao RZ, Han YH, Li AM.A case of severe side effects caused by methotrexate overdose. Chin J Practical Med 2008, 35: 88.
10.   Zhou GZ, Lv J, Shi YX, et al. A case of severe aplastic anemia caused by methotrexate overdose. J Naval Med 2010, 31: 96.
11.   He YL, Li CF, Shi L.A case of acute renal insufficiency caused by high dose methotrexate. Chin J Pediatrics 2007, 45: 78.
12.   Jiao SD.A New Exploration on the etiology, pathogenesis and treatment of Dalou. Study J Tradit Chin Med 2002, 20: 5-7.
13.   Fan WM, Li Y, Li JR.Experience in the differentiation and treatment of ankylosing spondylitis. Global TCM 2016, 19: 54-56.
14.   Song H, Hu ZY, Wu HS, et al. A comparative analysis of clinical characteristics of ankylosing spondylitis patients in North and South China. New Med 2011, 42: 147-153.
15.   Liang RG.Application of reinforcing liver and kidney and strengthening tendons and bones in the treatment of ankylosing spondylitis. China Modern Doctor 2010, 48: 48-49.
16.   Guo FX.Treating 50 cases of GanshenKuixu type of ankylosing spondylitis by BuganYishen therapy. Clinical J Chin Med 2015, 7: 54-55.
17.   He J.Clinical study of LiuweiDihuang Tang for the treatment of ankylosing spondylitis. Clinical Med Engineering 2011, 18: 420-421.
No related articles found!